|
| Exchange Disseminated Time | Lyka Labs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 28, 2014, has decided the following :
1. To re-appoint Shri. N. I. Gandhi as Managing Director for a period of 5 years w.e.f. April 01, 2014 subject to approval of Shareholders in the General Meeting and other Statutory Approvals.
2. To invest in 35,00,000 Equity Shares of Rs. 10/- each of Lyka Exports Limited at a premium of Rs. 25/- in lieu of its outstanding subject to approval of the Shareholders in the General Meeting.
3. To transfer Domestic Marketing Division of Ethical products under Slump Sale to Lyka Healthcare Ltd a wholly owned subsidiary Company w.e.f. March 01, 2014. |
|
|